Navigation Links
Accuray Incorporated to Present at Robert Baird 2009 Healthcare Conference
Date:9/4/2009

SUNNYVALE, Calif., Sept. 4 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that its management is scheduled to present at the Robert W. Baird 2009 Healthcare Conference in New York City on Thursday, September 10, 2009 at 11:00 a.m. ET (8:00 a.m. PT).

A live webcast of the presentation will be available online from the investor relations page of the Company's Web site at http://www.accuray.com. The webcast replay of the presentation will begin approximately one hour after the conclusion of the live presentation and will be available for approximately 30 days.

About the CyberKnife(R) Robotic Radiosurgery System

The CyberKnife Robotic Radiosurgery System is the world's only robotic radiosurgery system designed to treat tumors anywhere in the body non-invasively. Using continual image guidance technology and computer controlled robotic mobility, the CyberKnife System automatically tracks, detects and corrects for tumor and patient movement in real-time throughout the treatment. This enables the CyberKnife System to deliver high-dose radiation with pinpoint precision, which minimizes damage to surrounding healthy tissue and eliminates the need for invasive head or body stabilization frames.

About Accuray

Accuray Incorporated (Nasdaq: ARAY), based in Sunnyvale, Calif., is a global leader in the field of radiosurgery dedicated to providing an improved quality of life and a non-surgical treatment option for those diagnosed with cancer. Accuray develops and markets the CyberKnife Robotic Radiosurgery System, which extends the benefits of radiosurgery to include extracranial tumors, including those in the spine, lung, prostate, liver and pancreas. To date, the CyberKnife System has been used to treat more than 70,000 patients worldwide and currently 176 systems have been installed in leading hospitals in the Americas, Europe and Asia. For more information, please visit www.accuray.com.

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.

Euan Thomson, Ph.D.

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=81869

Omar Dawood, M.D., MPH

https://profnet.prnewswire.com/Subscriber/ExpertProfile.aspx?ei=85068



'/>"/>
SOURCE Accuray
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Accuray Incorporateds CEO to Speak at Piper Jaffray 19th Annual Health Care Conference
2. Accuray Announces New Treatment Planning Service Offering
3. Accuray to Present at Citi Investment Research Small & Mid-Cap Conference
4. Accuray Wins Innovations in Healthcare(SM) ABBY Award
5. Accuray Incorporateds CEO to Speak at CitiGroup Healthcare Conference
6. Accuray Announces Results for the Fourth Quarter and Fiscal Year End 2008
7. Accuray Incorporated to Host Investor and Analyst Meeting at ASTRO
8. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference
9. Accuray Reschedules Announcement of Results for First Quarter of Fiscal 2009
10. Accuray Postpones Release of First Quarter Fiscal 2009 Results
11. Accuray Achieves Milestone of 150th CyberKnife System Installed Worldwide
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)...  Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology ... announced that an Oncologic Drug Advisory Committee of ... to 0 that the benefit/risk of rituximab/hyaluronidase for ... patients in the proposed indications of follicular lymphoma, ... The FDA action date is June 26, 2017. ...
(Date:3/29/2017)... New Canaan, CT (PRWEB) , ... March 29, 2017 , ... ... of antibiotics and hormones in the world’s food supply through enhancement of the gut ... in the round included Connecticut Innovations , New York-based Sustainable Income Capital Management, ...
(Date:3/29/2017)... /PRNewswire/ -  GeneNews Limited (TSX:GEN) ("GeneNews" or the "Company") ... risk stratification test for breast cancer, via its ... BreastSentry incorporates a blood-based biomarker test with a sophisticated algorithm ... breast cancer.   ... BreastSentry measures the fasting plasma levels of two ...
(Date:3/28/2017)... ... March 28, 2017 , ... NetDimensions announced today that Scandinavian ... training plan management for consistent implementation of standards and regulatory requirements across SHL ... to help improve and streamline their training and employee development programs, which are ...
Breaking Biology Technology:
(Date:3/1/2017)... -- Aware, Inc. (NASDAQ: AWRE), a leading supplier of biometrics ... has resigned, effective March 3, 2017, as co-Chief ... Treasurer of Aware citing a desire to retire.  Mr. ... the Board of Directors of Aware. ... co-President, General Counsel has been named Chief Executive Officer, ...
(Date:2/26/2017)... , Feb. 25, 2017  Securus Technologies, ... technology solutions for public safety, investigation, corrections and ... Recidivism and Reentry. "Too often, too ... prisons and county jails are trying to tackle ... inmates and friends and family members. While significant steps ...
(Date:2/16/2017)... 16, 2017  Genos, a community for personal ... has received Laboratory Accreditation from the College of ... to laboratories that meet stringent requirements around quality, ... processes. "Genos is committed to maintaining ... We,re honored to be receiving CAP accreditation," said ...
Breaking Biology News(10 mins):